The retina revolution: signaling pathway therapies, genetic therapies, mitochondrial therapies, artificial intelligence.

Document Type

Article

Publication Date

5-1-2020

Publication Title

Current opinion in ophthalmology

Abstract

PURPOSE OF REVIEW: The aim of this article is to review and discuss the history, current state, and future implications of promising biomedical offerings in the field of retina.

RECENT FINDINGS: The technologies discussed are some of the more recent promising biomedical developments within the field of retina. There is a US Food and Drug Administration-approved gene therapy product and artificial intelligence device for retina, with many other offerings in the pipeline.

SUMMARY: Signaling pathway therapies, genetic therapies, mitochondrial therapies, and artificial intelligence have shaped retina care as we know it and are poised to further impact the future of retina care. Retina specialists have the privilege and responsibility of shaping this future for the visual health of current and future generations.

Volume

31

Issue

3

First Page

207

Last Page

214

DOI

10.1097/ICU.0000000000000656

ISSN

1531-7021

PubMed ID

32205471

Link to Full Text

Share

COinS